Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Anti-psoriatic Agent

Used topically or systemically, natural or synthetic Anti-psoriatic agents relieve symptoms of psoriasis by controlling rapid growth of skin cells… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND Corticosteroids remains compound of choice for topical treatment of psoriasis. Several side effects associated with… Expand
2018
2018
Psoriasis is a common inflammatory disease. It affects 1–3% of the population worldwide and is associated with increasing medical… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2016
2016
Recent evidence suggests that dimethylfumarate (DMF), known as a highly potent anti-psoriatic agent, might have anti-tumorigenic… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 5
Review
2014
Review
2014
The continuous discovery of new T cell subpopulations in human autoimmune diseases is making the immunopathological network more… Expand
  • figure 1
  • figure 2
  • table 1
Highly Cited
2007
Highly Cited
2007
The aim of the current investigation is to evaluate the transdermal potential of novel vesicular carrier, ethosomes, bearing… Expand
Highly Cited
2001
Highly Cited
2001
Psoriasis is a hyperproliferative skin disorder estimated to be present in 1-3% of most populations. Conventional therapy using… Expand
Review
2001
Review
2001
Publisher Summary The pathogenesis of psoriasis involves abnormal differentiation and hyperproliferation of keratinocytes… Expand
1991
1991
1,25-dihydroxyvitamin D3 (1,25(OH)2D3) is suggested to be involved in the regulation of keratinocyte proliferation and… Expand